文献速递消化道肿瘤与早癌消化内镜

45-49岁与50-54岁成人结直肠癌粪便免疫化学检测筛查效果比较

Yield of Fecal Immunochemical Test Screening for Colorectal Cancer in Adults Aged 45-49 vs 50-54 Years.
PubMed 文献 · Am J Gastroenterol · 2026-06-24

在中国省级结直肠癌筛查项目中,比较45-49岁与50-54岁人群基于粪便免疫化学检测(FIT)的筛查效果,共纳入733,137名参与者。45-49岁组FIT阳性率和结肠镜完成率更高,但进展期肿瘤和任何腺瘤的检出率显著低于50-54岁组;在具有明确危险因素(如吸烟、频繁饮酒、男性)的45-49岁个体中,检出率与50-54岁组相当。

要点

  • 45-49岁人群FIT阳性率10.61%、结肠镜完成率46.75%,均高于50-54岁组。
  • 45-49岁组进展期肿瘤检出率0.30% vs 0.39%(aRR 0.78),任何腺瘤0.78% vs 0.95%(aRR 0.83)。
  • 在吸烟、频繁饮酒或男性等风险升高的45-49岁个体中,检出率与50-54岁组相当。

核心结论

  • 45-49岁成人基于FIT的结直肠癌筛查参与度更高但筛查产出低于50-54岁成人。
  • 在年轻人群中应优先考虑具有 elevated 风险特征(如吸烟、频繁饮酒、男性)的个体进行结直肠癌筛查。

研究设计与样本

  • 在中国省级结直肠癌筛查项目中开展的研究,采用两样本FIT筛查,阳性者行结肠镜检查。
  • 共纳入733,137名参与者,其中45-49岁89,446人,50-54岁643,691人。
  • 采用稳健泊松回归估计调整风险比(aRR),以50-54岁组为参照。

主要发现

  • 45-49岁组FIT阳性率为10.61%,结肠镜完成率为46.75%,均高于50-54岁组。
  • 45-49岁组进展期肿瘤检出率为0.30%,50-54岁组为0.39%;aRR为0.78(95%CI 0.68-0.88)。
  • 45-49岁组任何腺瘤检出率为0.78%,50-54岁组为0.95%;aRR为0.83(95%CI 0.77-0.90)。
  • 阳性预测值(PPV)在两组间也观察到类似差异。
  • 在45-49岁组内,具有明确危险因素的个体检出率与50-54岁组相当,其中吸烟者RR为1.50(95%CI 1.22-1.84),频繁饮酒者RR为1.33(95%CI 1.01-1.75),男性RR为1.20(95%CI 1.03-1.40)。

临床怎么用

  • 对于45-49岁人群,基于FIT的结直肠癌筛查应优先覆盖具有吸烟、频繁饮酒或男性等风险升高的个体。
  • 临床解读45-49岁人群FIT筛查结果时,需注意其进展期肿瘤和腺瘤检出率总体低于50-54岁人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The rising incidence of early-onset colorectal cancer (CRC) has prompted debate over lowering screening initiation age. However, real-world evidence on fecal immunochemical test (FIT)-based screening effectiveness in 45-49 years remains limited. The aim of our study was to evaluate screening yield of FIT-based CRC screening between 45-49 and 50-54 years. METHODS: Conducted within a provincial CRC screening program in China, this study used 2-sample FIT screening followed by colonoscopy for positive results. Screening outcomes, including FIT positivity, colonoscopy completion, positive predictive values (PPVs) and detection rates of adenoma and advanced colorectal neoplasia, were compared between participants aged 45-49 and 50-54 years. Robust Poisson regression was used to estimate adjusted risk ratios (aRRs), using 50-54-year-old age group as reference. RESULTS: Among 733,137 participants, 89,446 were aged 45-49 years and 643,691 aged 50-54 years. Participants aged 45-49 years had higher FIT positivity (10.61%) and colonoscopy completion (46.75%) than those aged 50-54 years. However, detection rates for advanced neoplasia (0.30% vs 0.39%; aRR, 0.78; 95% confidence interval [CI], 0.68-0.88) and any adenoma (0.78% vs 0.95%; aRR, 0.83; 95% CI, 0.77-0.90) were significantly lower in the younger group, with similar results observed for PPVs. Within the 45-49-year-old age group, comparable detection rates to 50-54-year-old age group were observed among individuals with established risk factors, most notably among smokers (RR, 1.50; 95% CI, 1.22-1.84), frequent alcohol drinkers (RR, 1.33; 95% CI, 1.01-1.75), and men (RR, 1.20; 95% CI, 1.03-1.40). DISCUSSION: Overall, adults aged 45-49 years showed higher screening participation but lower screening yield than those aged 50-54 years. These findings highlight the importance of prioritizing individuals with elevated risk profiles for CRC screening in younger populations.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Wang L, Zhu C, Qiu Y, et al. Yield of Fecal Immunochemical Test Screening for Colorectal Cancer in Adults Aged 45-49 vs 50-54 Years. Am J Gastroenterol. 2026. PMID: 42335418. doi:10.14309/ajg.0000000000004087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。